Study S001512

Obesity Complicating Type 1 Diabetes in Young Adults: Physiology and Impact of GLP-1 Analogue Anti-obesity Treatment on Cardiometabolic Risk Factors

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06411210
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: RECRUITING
Enrollment: 54
Start: 2024-07-16
Primary completion: 2028-04-30
Lead sponsor: Yale University
Conditions: Diabetes type1; Obesity
Interventions: DRUG:Semaglutide Pen Injector; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:1R01DK134398-01A1

Registered primary outcomes

Change in VAT/(VAT+SAT) from baseline to 12 months [baseline and 12 months]
Change in hepatic insulin resistance from baseline to 12 months [baseline and 12 months]
Change in triglycerides from baseline to 12 months [baseline and 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.